1 / 6

Living Donor Committee

Living Donor Committee. Fall 2012 Public Comment Cycle. New Policies for Living Kidney Donor Informed Consent, Medical Evaluation, and Follow-Up. Approved by the OPTN/UNOS Board during its November 2012 meeting Policy notice outlining the new requirements will be distributed in mid-December

rene
Download Presentation

Living Donor Committee

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Living Donor Committee Fall 2012 Public Comment Cycle

  2. New Policies for Living Kidney Donor Informed Consent, Medical Evaluation, and Follow-Up • Approved by the OPTN/UNOS Board during its November 2012 meeting • Policy notice outlining the new requirements will be distributed in mid-December • OPTN website will be updated to reflect new policies in mid- December • Policies take effect on February 1, 2013

  3. New Policies for Living Kidney Donor Informed Consent, Medical Evaluation, and Follow-Up • New requirements for living donor follow-up only apply to living kidney donors who donate after February 1, 2013 and will initially require: • Donor Status and Clinical Information for 60% of living kidney donors • Laboratory Data for 50% of living kidney donors

  4. New Policies for Living Kidney Donor Informed Consent, Medical Evaluation, and Follow-Up • UNOS will provide a webcast to introduce these new policy requirements on January 15, 2013 • Checklists addressing all required elements of the consent and medical evaluation policies have been developed and will be available for voluntary use by centers • Interviewing centers with successful donor follow-up to update the best practices resource available on the OPTN website

  5. Living Donation Policy in Development • Spring 2013 Public Comment • Independent Donor Advocate Policy Proposal • IDA may be an individual or IDA team • Role of the IDA • Requirements for the IDA • Qualifications of the IDA • Policy proposals for the consent, medical evaluation and follow-up of living liver donors

  6. Questions? • Christie Thomas, Chair christie-thomas@uiowa.edu • Sandra Taler, Vice Chair staler@mayo.edu • Lee Bolton, Liaison Lee.Bolton@unos.org

More Related